These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 38480828)

  • 1. Association between nonalcoholic fatty liver disease and gallstone risk in nonobese and lean individuals.
    Kim NH; Kang JH; Kim HJ
    Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):945-951. PubMed ID: 38652507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary characteristics associated with the risk of non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease in non-obese Japanese participants: A cross-sectional study.
    Taniguchi H; Ueda M; Sano F; Kobayashi Y; Shima T
    JGH Open; 2024 May; 8(5):e13082. PubMed ID: 38779132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between systemic inflammation indicators and nonalcoholic fatty liver disease: evidence from a prospective study.
    Gong H; He Q; Zhu L; Feng Z; Sun M; Jiang J; Yuan X; Shen Y; Di J
    Front Immunol; 2024; 15():1389967. PubMed ID: 38979415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipid metabolism-related genotypes of PLA2R1 and CERS4 contribute to nonobese MASLD.
    Shao C; Ye J; Dong Z; Liao B; Feng S; Hu S; Zhong B
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38836837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between platelet-related parameters and nonalcoholic fatty liver disease in a metabolically healthy nonobese population.
    Choe EK; Kang HY
    Sci Rep; 2024 Mar; 14(1):6118. PubMed ID: 38480828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of platelet-related parameters for the prediction of NAFLD in OSAHS patients.
    Chen M; Wang B; Huang J; Zhao J; Chen J; Chen G
    BMC Pulm Med; 2022 Dec; 22(1):487. PubMed ID: 36566219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk.
    Liu K; Tang S; Liu C; Ma J; Cao X; Yang X; Zhu Y; Chen K; Liu Y; Zhang C; Liu Y
    Front Immunol; 2024; 15():1337241. PubMed ID: 38481995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic Fatty Liver Disease and Mean Platelet Volume: A Systemic Review and Meta-analysis.
    Madan SA; John F; Pitchumoni CS
    J Clin Gastroenterol; 2016 Jan; 50(1):69-74. PubMed ID: 25984978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-associated biomarkers in nonalcoholic steatohepatitis: Insights from a female cohort with obesity.
    Duran-Bertran J; Rusu EC; Barrientos-Riosalido A; Bertran L; Mahmoudian R; Aguilar C; Riesco D; Martínez S; Ugarte Chicote J; Sabench F; Richart C; Auguet T
    Eur J Clin Invest; 2024 Mar; 54(3):e14123. PubMed ID: 37929908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with nonalcoholic fatty liver disease: a cross-sectional study.
    Zhou Y; Tian N; Li P; He Y; Tong L; Xie W
    Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1158-1164. PubMed ID: 36170685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing from NAFLD through MAFLD to MASLD: Similar prevalence and risk factors in a large Brazilian cohort.
    Perazzo H; Pacheco AG; Griep RH;
    J Hepatol; 2024 Feb; 80(2):e72-e74. PubMed ID: 37678721
    [No Abstract]   [Full Text] [Related]  

  • 12. Can we use old NAFLD data under the new MASLD definition?
    Song SJ; Lai JC; Wong GL; Wong VW; Yip TC
    J Hepatol; 2024 Feb; 80(2):e54-e56. PubMed ID: 37541393
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of changes in body mass index and waist circumference with cardiovascular risk in non-alcoholic fatty liver disease: A nationwide study.
    Jang SY; Kim HJ; Chang JY
    Dig Liver Dis; 2023 Nov; 55(11):1509-1514. PubMed ID: 37419727
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.